Annual ROA
-109.34%
-45.14%-70.31%
31 December 2023
Summary:
Chemomab Therapeutics annual return on assets is currently -109.34%, with the most recent change of -45.14% (-70.31%) on 31 December 2023. During the last 3 years, it has fallen by -61.64% (-129.22%). CMMB annual ROA is now -463.90% below its all-time high of -19.39%, reached on 31 December 2021.CMMB ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROA
-76.18%
+6.06%+7.37%
01 September 2024
Summary:
Chemomab Therapeutics quarterly return on assets is currently -76.18%, with the most recent change of +6.06% (+7.37%) on 01 September 2024. Over the past year, it has increased by +5.40% (+6.62%). CMMB quarterly ROA is now -375.23% below its all-time high of -16.03%, reached on 30 June 2021.CMMB Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CMMB ROA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -70.3% | +6.6% |
| 3 y3 years | -129.2% | -327.0% |
| 5 y5 years | - | - |
CMMB ROA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -463.9% | at low | -327.0% | +9.8% |
| 5 y | 5 years | -463.9% | at low | -375.2% | +9.8% |
| alltime | all time | -463.9% | at low | -375.2% | +9.8% |
Chemomab Therapeutics ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -76.18%(-7.4%) |
| June 2024 | - | -82.24%(-2.2%) |
| Mar 2024 | - | -84.06%(-0.5%) |
| Dec 2023 | -109.34%(+70.3%) | -84.48%(+3.6%) |
| Sept 2023 | - | -81.58%(-3.1%) |
| June 2023 | - | -84.19%(+24.2%) |
| Mar 2023 | - | -67.78%(+29.1%) |
| Dec 2022 | -64.20% | -52.51%(+24.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | -42.10%(+35.9%) |
| June 2022 | - | -30.98%(+28.4%) |
| Mar 2022 | - | -24.12%(+26.8%) |
| Dec 2021 | -19.39%(-59.4%) | -19.02%(+6.6%) |
| Sept 2021 | - | -17.84%(+11.3%) |
| June 2021 | - | -16.03%(-2.4%) |
| Mar 2021 | - | -16.42%(-65.6%) |
| Dec 2020 | -47.70% | -47.70% |
FAQ
- What is Chemomab Therapeutics annual return on assets?
- What is the all time high annual ROA for Chemomab Therapeutics?
- What is Chemomab Therapeutics annual ROA year-on-year change?
- What is Chemomab Therapeutics quarterly return on assets?
- What is the all time high quarterly ROA for Chemomab Therapeutics?
- What is Chemomab Therapeutics quarterly ROA year-on-year change?
What is Chemomab Therapeutics annual return on assets?
The current annual ROA of CMMB is -109.34%
What is the all time high annual ROA for Chemomab Therapeutics?
Chemomab Therapeutics all-time high annual return on assets is -19.39%
What is Chemomab Therapeutics annual ROA year-on-year change?
Over the past year, CMMB annual return on assets has changed by -45.14% (-70.31%)
What is Chemomab Therapeutics quarterly return on assets?
The current quarterly ROA of CMMB is -76.18%
What is the all time high quarterly ROA for Chemomab Therapeutics?
Chemomab Therapeutics all-time high quarterly return on assets is -16.03%
What is Chemomab Therapeutics quarterly ROA year-on-year change?
Over the past year, CMMB quarterly return on assets has changed by +5.40% (+6.62%)